BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Arslan S, Manduz Ş, Epöztürk K, Karahan O, Akkurt İ. Association of deep venous thrombosis with prothrombotic gene polymorphism identified in lung cancer cases. Mol Biol Rep 2011;38:2395-400. [DOI: 10.1007/s11033-010-0373-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Kang JR, Long LH, Yan SW, Wei WW, Jun HZ, Chen W. Peripherally Inserted Central Catheter-Related Vein Thrombosis in Patients With Lung Cancer. Clin Appl Thromb Hemost 2017;23:181-6. [DOI: 10.1177/1076029615595880] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
2 Buijs JT, Versteeg HH. Genes and proteins associated with the risk for cancer-associated thrombosis. Thrombosis Research 2020;191:S43-9. [DOI: 10.1016/s0049-3848(20)30396-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ghaznavi H, Soheili Z, Samiei S, Soltanpour MS. Association of Methylenetetrahydrofolate Reductase C677T Polymorphism with Hyperhomocysteinemia and Deep Vein Thrombosis in the Iranian Population. Vasc Specialist Int 2015;31:109-14. [PMID: 26719836 DOI: 10.5758/vsi.2015.31.4.109] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
4 Li H, Zhang B, Lu S, Ji DG, Ding M, Ye YS, Sun DJ. siRNA-mediated silencing of PAI-1 gene acts as a promoter over the recanalization of endothelial progenitor cells in rats with venous thrombosis. J Cell Physiol 2019;234:19921-32. [PMID: 30982977 DOI: 10.1002/jcp.28590] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Hoteit R, Hassanieh S, Mahfouz RA. Comparison of the performance of the Cepheid Xpert HemosIL Factor II and Factor V and the ViennaLab FV-PTH-MTHFR StripAssay kits for molecular thrombophilia profiling. Genet Test Mol Biomarkers 2014;18:183-6. [PMID: 24401045 DOI: 10.1089/gtmb.2013.0379] [Reference Citation Analysis]
6 Hoteit R, Taher A, Nassar R, Otrock Z, Halawi R, Mahfouz RA. Frequency of Triple Mutations Involving Factor V, Prothrombin, and Methylenetetrahydrofolate Reductase Genes Among Patients Referred for Molecular Thrombophilia Workup in a Tertiary Care Center in Lebanon. Genetic Testing and Molecular Biomarkers 2012;16:223-5. [DOI: 10.1089/gtmb.2011.0114] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
7 Bozok Çetintaş V, Gündüz C. Association between polymorphism of MTHFR c.677C>T and risk of cardiovascular disease in Turkish population: a meta-analysis for 2.780 cases and 3.022 controls. Mol Biol Rep 2014;41:397-409. [PMID: 24264431 DOI: 10.1007/s11033-013-2873-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
8 Gao M, Wang Y, Shi Y, Liu D, Liang Y, Yu Y, Zhaobin J, Zhu L, Jin S. The relationship between three well-characterized polymorphisms of the angiotensin converting enzyme gene and lung cancer risk: a case-control study and a meta-analysis. J Renin Angiotensin Aldosterone Syst 2012;13:455-60. [PMID: 22538550 DOI: 10.1177/1470320312443912] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
9 Pabinger I, Ay C, Dunkler D, Thaler J, Reitter EM, Marosi C, Zielinski C, Mannhalter C. Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients - results from the Vienna Cancer And Thrombosis Study (CATS). J Thromb Haemost 2015;13:17-22. [PMID: 25381723 DOI: 10.1111/jth.12778] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
10 Zhang Q, Jin Y, Li X, Peng X, Peng N, Song J, Xu M. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism – a meta-analysis and systematic review. Vasa 2020;49:141-6. [DOI: 10.1024/0301-1526/a000839] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 40.0] [Reference Citation Analysis]
11 Boersma RS, Hamulyak K, van Oerle R, Tuinenburg A, Ten Cate-Hoek AJ, Schouten HC. Biomarkers for Prediction of Central Venous Catheter Related-Thrombosis in Patients With Hematological Malignancies. Clin Appl Thromb Hemost 2016;22:779-84. [PMID: 25888571 DOI: 10.1177/1076029615579098] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
12 Heenkenda MK, Malmström A, Lysiak M, Mudaisi M, Bratthäll C, Milos P, Strandeus M, Åkesson L, Söderkvist P, Uppugunduri S, Osman A. Assessment of genetic and non-genetic risk factors for venous thromboembolism in glioblastoma - The predictive significance of B blood group. Thromb Res 2019;183:136-42. [PMID: 31677594 DOI: 10.1016/j.thromres.2019.10.009] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Wang J, Wang C, Chen N, Shu C, Guo X, He Y, Zhou Y. Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: a meta-analysis. Thromb Res 2014;134:1241-8. [PMID: 25450536 DOI: 10.1016/j.thromres.2014.09.035] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
14 Ghasemi S, Tavakoli A, Moghadam M, Zargar MA, Abbaspour M, Hatamnejadian N, Ebrahimi A. Risk of prostate cancer and thrombosis-related factor polymorphisms. Biomed Rep 2014;2:53-6. [PMID: 24649068 DOI: 10.3892/br.2013.180] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
15 Alexander M, Burbury K. A systematic review of biomarkers for the prediction of thromboembolism in lung cancer - Results, practical issues and proposed strategies for future risk prediction models. Thromb Res 2016;148:63-9. [PMID: 27815968 DOI: 10.1016/j.thromres.2016.10.020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]